News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
748,331 Results
Type
Article (52090)
Company Profile (313)
Press Release (695928)
Multimedia
Podcasts (70)
Webinars (13)
Section
Business (214841)
Career Advice (2210)
Deals (36873)
Drug Delivery (106)
Drug Development (84705)
Employer Resources (179)
FDA (17150)
Job Trends (15923)
News (363493)
Policy (35029)
Tag
Academia (2865)
Accelerated approval (5)
Adcomms (24)
Allergies (91)
Alliances (52581)
ALS (103)
Alzheimer's disease (1464)
Antibody-drug conjugate (ADC) (149)
Approvals (17139)
Artificial intelligence (296)
Autoimmune disease (26)
Automation (17)
Bankruptcy (377)
Best Places to Work (12257)
BIOSECURE Act (19)
Biosimilars (111)
Biotechnology (215)
Bladder cancer (86)
Brain cancer (28)
Breast cancer (306)
Cancer (2433)
Cardiovascular disease (193)
Career advice (1857)
Career pathing (31)
CAR-T (162)
Cell therapy (460)
Cervical cancer (22)
Clinical research (68830)
Collaboration (918)
Company closure (2)
Compensation (569)
Complete response letters (25)
COVID-19 (2743)
CRISPR (45)
C-suite (269)
Cystic fibrosis (105)
Data (2371)
Decentralized trials (2)
Denatured (29)
Depression (52)
Diabetes (287)
Diagnostics (6703)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (127)
Drug pricing (113)
Drug shortages (28)
Duchenne muscular dystrophy (99)
Earnings (89809)
Editorial (42)
Employer branding (21)
Employer resources (152)
Events (119614)
Executive appointments (775)
FDA (18585)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (818)
Gene editing (117)
Generative AI (28)
Gene therapy (341)
GLP-1 (794)
Government (4769)
Grass and pollen (5)
Guidances (158)
Healthcare (20216)
Huntington's disease (25)
IgA nephropathy (27)
Immunology and inflammation (136)
Indications (30)
Infectious disease (2899)
Inflammatory bowel disease (152)
Inflation Reduction Act (9)
Influenza (57)
Intellectual property (102)
Interviews (346)
IPO (17035)
IRA (41)
Job creations (4099)
Job search strategy (1581)
Kidney cancer (11)
Labor market (43)
Layoffs (512)
Leadership (20)
Legal (8517)
Liver cancer (80)
Lung cancer (346)
Lymphoma (159)
Machine learning (9)
Management (61)
Manufacturing (341)
MASH (80)
Medical device (14444)
Medtech (14449)
Mergers & acquisitions (20416)
Metabolic disorders (762)
Multiple sclerosis (87)
NASH (18)
Neurodegenerative disease (110)
Neuropsychiatric disorders (32)
Neuroscience (2063)
NextGen: Class of 2025 (7020)
Non-profit (4856)
Now hiring (40)
Obesity (405)
Opinion (229)
Ovarian cancer (84)
Pain (98)
Pancreatic cancer (90)
Parkinson's disease (162)
Partnered (22)
Patents (251)
Patient recruitment (118)
Peanut (49)
People (60868)
Pharmaceutical (70)
Pharmacy benefit managers (22)
Phase I (21481)
Phase II (30234)
Phase III (22574)
Pipeline (1405)
Policy (152)
Postmarket research (2777)
Preclinical (9178)
Press Release (70)
Prostate cancer (113)
Psychedelics (34)
Radiopharmaceuticals (263)
Rare diseases (412)
Real estate (6406)
Recruiting (67)
Regulatory (23995)
Reports (47)
Research institute (2546)
Resumes & cover letters (368)
Rett syndrome (6)
RNA editing (5)
RSV (45)
Schizophrenia (80)
Series A (139)
Series B (93)
Service/supplier (14)
Sickle cell disease (57)
Special edition (17)
Spinal muscular atrophy (154)
Sponsored (32)
Startups (3905)
State (2)
Stomach cancer (16)
Supply chain (73)
Tariffs (50)
The Weekly (39)
Vaccines (753)
Venture capitalists (44)
Weight loss (277)
Women's health (39)
Worklife (17)
Date
Today (177)
Last 7 days (1009)
Last 30 days (3217)
Last 365 days (33872)
2025 (12361)
2024 (36711)
2023 (41682)
2022 (52930)
2021 (57714)
2020 (56476)
2019 (49459)
2018 (37438)
2017 (34254)
2016 (34103)
2015 (40200)
2014 (33845)
2013 (29119)
2012 (31411)
2011 (32081)
2010 (30443)
Location
Africa (818)
Alabama (55)
Alaska (7)
Arizona (245)
Arkansas (14)
Asia (41805)
Australia (6918)
California (6563)
Canada (2093)
China (569)
Colorado (286)
Connecticut (302)
Delaware (163)
Europe (91545)
Florida (968)
Georgia (227)
Idaho (61)
Illinois (597)
India (26)
Indiana (338)
Iowa (11)
Japan (175)
Kansas (110)
Kentucky (27)
Louisiana (12)
Maine (62)
Maryland (969)
Massachusetts (4941)
Michigan (249)
Minnesota (424)
Mississippi (2)
Missouri (84)
Montana (30)
Nebraska (25)
Nevada (70)
New Hampshire (69)
New Jersey (1847)
New Mexico (31)
New York (1846)
North Carolina (1091)
North Dakota (9)
Northern California (2873)
Ohio (216)
Oklahoma (14)
Oregon (36)
Pennsylvania (1448)
Puerto Rico (13)
Rhode Island (35)
South America (1218)
South Carolina (26)
South Dakota (1)
Southern California (2461)
Tennessee (108)
Texas (976)
United States (24880)
Utah (198)
Virginia (160)
Washington D.C. (70)
Washington State (593)
West Virginia (3)
Wisconsin (61)
748,331 Results for "advanced medical optics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Precision Optics Reports Third Quarter Fiscal Year 2024 Financial Results
Precision Optics Corporation, Inc., a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its third quarter fiscal year 2024 for the period ended March 31, 2024.
May 15, 2024
·
12 min read
Press Releases
Precision Optics Schedules Third Quarter of Fiscal Year 2025 Conference Call for May 15, 2025
May 9, 2025
·
4 min read
Press Releases
Optic Neuropathy Market Size to Reach USD 4.6 Billion by 2035, Impelled by Advances in Personalized and Precision Medicine
February 7, 2025
·
11 min read
Press Releases
AI Optics Receives FDA Clearance, Increasing Patient Access to Retinal Screening
January 29, 2025
·
3 min read
Press Releases
Precision Optics Appoints Joseph P. Pellegrino, Jr. to Board of Directors
March 20, 2025
·
5 min read
Press Releases
Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation
March 17, 2025
·
4 min read
Genetown
Precision Optics Announces Record $9 Million Production Order for High Volume Single-Use Cystoscopy Surgery Program
Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today announced a $9 million production order from a leading surgical company to supply single-use endoscope assemblies used in their cystoscopy surgery system.
May 9, 2024
·
4 min read
Business
Precision Optics Corporation Schedules Third Quarter of Fiscal Year 2024 Conference Call for Wednesday, May 15, 2024
Precision Optics Corporation, Inc., a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced that it has scheduled a conference call to discuss third quarter of fiscal year 2024 financial results on Wednesday, May 15, 2024, at 5:00pm ET.
May 8, 2024
·
3 min read
Pharm Country
Syntec Optics (Nasdaq: OPTX) Secures Order to Develop New Disposable Optics for Digital Health Treatment
Syntec Optics announced today the launch of process development for a high-volume production line to make disposable medical optics.
April 12, 2024
·
5 min read
Press Releases
Oragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment
February 25, 2025
·
3 min read
1 of 74,834
Next
